NO20054375L - Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner - Google Patents
Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinolinerInfo
- Publication number
- NO20054375L NO20054375L NO20054375A NO20054375A NO20054375L NO 20054375 L NO20054375 L NO 20054375L NO 20054375 A NO20054375 A NO 20054375A NO 20054375 A NO20054375 A NO 20054375A NO 20054375 L NO20054375 L NO 20054375L
- Authority
- NO
- Norway
- Prior art keywords
- cyano
- nitro
- alkoxy
- anthranilate
- quinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Det tilveiebringes en fremgangsmåte for fremstilling av 3-cyano-6-alkoksy-7-nitro-4-kinolon-mellomprodukter anvendelige for fremstilling av proteintyrosinkinase-(PTK)-inhibitorer som er anvendelige ved behandling av kreft med formelen: hvor R er alkyl(CrC3) fremstilt ved omsetning av et substituert antranilat med N,N-dimetylformamid dimetylacetal for å oppnå et N,N-dimetylamidin som blir kondensert med t-butylcyanoacetat for å oppnå et N-(2-cyano-2-t-butoksykarbonylvinyl)antranilat, som blir hydrolysert, hvilket gir et N-(2-cyano-2-karboksyvinyl)antranilat fulgt av dekarboksylering for å oppnå et N-(2-cyano-2-karboksyvinyl)antranilat fulgt av cyklisering for å oppnå en 3-cyano-6-alkoksy-7-nitro-4-kinolon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46164703P | 2003-04-09 | 2003-04-09 | |
PCT/US2004/010190 WO2004092138A1 (en) | 2003-04-09 | 2004-04-02 | Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20054375L true NO20054375L (no) | 2005-10-12 |
Family
ID=33299849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054375A NO20054375L (no) | 2003-04-09 | 2005-09-21 | Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner |
Country Status (21)
Country | Link |
---|---|
US (1) | US6933388B2 (no) |
EP (1) | EP1611103A1 (no) |
JP (1) | JP2006522810A (no) |
KR (1) | KR20050120788A (no) |
CN (1) | CN100376558C (no) |
AR (1) | AR043988A1 (no) |
AU (1) | AU2004230864A1 (no) |
BR (1) | BRPI0409134A (no) |
CA (1) | CA2521294A1 (no) |
CL (1) | CL2004000758A1 (no) |
CO (1) | CO5640089A2 (no) |
CR (1) | CR7991A (no) |
EC (1) | ECSP056089A (no) |
EG (1) | EG24122A (no) |
MX (1) | MXPA05010685A (no) |
NI (1) | NI200500175A (no) |
NO (1) | NO20054375L (no) |
RU (1) | RU2333909C2 (no) |
TW (1) | TW200504024A (no) |
UA (1) | UA80607C2 (no) |
WO (1) | WO2004092138A1 (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101723854A (zh) * | 2008-10-24 | 2010-06-09 | 上海特化医药科技有限公司 | 6-取代氨基-3-氰基喹啉类化合物的制备方法及其中间体 |
CN111116416B (zh) * | 2019-12-30 | 2021-03-23 | 中国农业大学 | 一种β-氨基丙烯腈类化合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
AU6159499A (en) * | 1998-09-29 | 2000-04-17 | Wyeth Holdings Corporation | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
-
2004
- 2004-02-04 UA UAA200510561A patent/UA80607C2/uk unknown
- 2004-04-01 TW TW093109053A patent/TW200504024A/zh unknown
- 2004-04-02 WO PCT/US2004/010190 patent/WO2004092138A1/en active Application Filing
- 2004-04-02 RU RU2005134653/04A patent/RU2333909C2/ru active
- 2004-04-02 AU AU2004230864A patent/AU2004230864A1/en not_active Abandoned
- 2004-04-02 MX MXPA05010685A patent/MXPA05010685A/es active IP Right Grant
- 2004-04-02 JP JP2006509628A patent/JP2006522810A/ja active Pending
- 2004-04-02 EP EP04759094A patent/EP1611103A1/en not_active Withdrawn
- 2004-04-02 BR BRPI0409134-5A patent/BRPI0409134A/pt not_active IP Right Cessation
- 2004-04-02 KR KR1020057019108A patent/KR20050120788A/ko not_active Application Discontinuation
- 2004-04-02 CA CA002521294A patent/CA2521294A1/en not_active Abandoned
- 2004-04-02 CN CNB2004800094145A patent/CN100376558C/zh not_active Expired - Fee Related
- 2004-04-06 AR ARP040101163A patent/AR043988A1/es unknown
- 2004-04-07 US US10/820,115 patent/US6933388B2/en not_active Expired - Fee Related
- 2004-04-07 CL CL200400758A patent/CL2004000758A1/es unknown
-
2005
- 2005-09-14 CR CR7991A patent/CR7991A/es not_active Application Discontinuation
- 2005-09-21 NO NO20054375A patent/NO20054375L/no not_active Application Discontinuation
- 2005-10-05 EG EGNA2005000622 patent/EG24122A/xx active
- 2005-10-05 CO CO05101169A patent/CO5640089A2/es not_active Application Discontinuation
- 2005-10-07 NI NI200500175A patent/NI200500175A/es unknown
- 2005-10-07 EC EC2005006089A patent/ECSP056089A/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050120788A (ko) | 2005-12-23 |
AU2004230864A1 (en) | 2004-10-28 |
TW200504024A (en) | 2005-02-01 |
ECSP056089A (es) | 2006-03-01 |
AR043988A1 (es) | 2005-08-17 |
BRPI0409134A (pt) | 2006-03-28 |
US20040204587A1 (en) | 2004-10-14 |
WO2004092138A1 (en) | 2004-10-28 |
MXPA05010685A (es) | 2005-12-12 |
EG24122A (en) | 2008-07-06 |
EP1611103A1 (en) | 2006-01-04 |
CL2004000758A1 (es) | 2005-02-04 |
NI200500175A (es) | 2006-05-04 |
CN1771230A (zh) | 2006-05-10 |
CN100376558C (zh) | 2008-03-26 |
CR7991A (es) | 2006-05-31 |
RU2005134653A (ru) | 2006-03-27 |
RU2333909C2 (ru) | 2008-09-20 |
JP2006522810A (ja) | 2006-10-05 |
UA80607C2 (en) | 2007-10-10 |
CA2521294A1 (en) | 2004-10-28 |
US6933388B2 (en) | 2005-08-23 |
CO5640089A2 (es) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300877I2 (nl) | obeticholzuur | |
ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
MY136959A (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
NO20070917L (no) | Imidazotriaziner som protein-kinaseinhibitorer | |
DE60130771D1 (de) | Substituierte heterocyclische amide | |
CY1108908T1 (el) | Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4 | |
NO20062136L (no) | Imidazopyrazintyrosin-kinaseinhibitorer | |
PL1781683T3 (pl) | Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich | |
NO20083411L (no) | Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling | |
ME01395B (me) | Postupak za izradu (1s)-4,5-dimetoksi-1-(metilaminometil)benzociklobutanai njegovih aditivnih soli kiselina kao i njegov a primena za sintezu ivabradina i njegovih farmaceutski prihvatljivih aditivnih soli kiselina | |
EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
HRP20060124A2 (en) | Process for the preparation of n-amino substituted heterocyclic compounds | |
NO20063324L (no) | 3-cyano-kinolinderivater med antiproliferativ aktivitet | |
NO20053561L (no) | Mettede kinoksalinderivater og deres anvendelse som metabotrofe og glutamatreseptorligander | |
GEP20084494B (en) | New heterocyclic carboxylic acid amide derivatives | |
NO20052443D0 (no) | 7-fenylpyrazolpyridinforbindelser | |
ATE505462T1 (de) | Neue biologischaktive molekü le | |
TW200628153A (en) | Novel compounds | |
NO20054375L (no) | Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner | |
EA200301317A1 (ru) | Производные аминохинолина и его применение в качестве лигандов аденозина a3 | |
EA200700767A1 (ru) | Способ получения пиразолов | |
NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
ATE239722T1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
EA200800633A1 (ru) | Способ получения производных сартана и промежуточных соединений, пригодных для этого способа | |
EA200870405A1 (ru) | Способ получения гетероциклических производных |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |